ABSTRACT
An expanding body of evidence emphasizes the role of platelets as initial actors in inflammatory diseases such as atherosclerosis. Platelets interact with leukocytes and endothelial cells and enforce monocyte transformation into macrophages. Platelets not only mediate the recruitment of leukocytes. They also bind oxidized phospholipids and may promote foam cell formation. Platelets furthermore recruit progenitor cells to the scene, which are able to differentiate into foam cells or endothelial cells, presumably depending on the local microenvironment. Furthermore, platelets are capable of promoting the recruitment of circulating dendritic cells and influencing their functions, thereby presumably modulating immune reactions in atherogenesis. Taken together, platelets may participate in the initiation, development, and total extent of atherosclerotic lesions.
KEYWORDS
Endothelium - platelets - inflammatory response - atherosclerosis - coronary artery disease - atherothrombosis
REFERENCES
-
1
Savage B, Saldivar E, Ruggeri Z M.
Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.
Cell.
1996;
84(2)
289-297
-
2
Ware J, Russell S, Ruggeri Z M.
Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.
Proc Natl Acad Sci U S A.
2000;
97(6)
2803-2808
-
3
Uff S, Clemetson J M, Harrison T, Clemetson K J, Emsley J.
Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation.
J Biol Chem.
2002;
277(38)
35657-35663
-
4
Massberg S, Gawaz M, Gruner S et al..
A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo.
J Exp Med.
2003;
197(1)
41-49
-
5
Massberg S, Konrad I, Bultmann A et al..
Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
FASEB J.
2004;
18(2)
397-399
-
6
Nieswandt B, Watson S P.
Platelet-collagen interaction: is GPVI the central receptor?.
Blood.
2003;
102(2)
449-461
-
7
Gawaz M.
Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium.
Cardiovasc Res.
2004;
61(3)
498-511
-
8
Langer H, Gawaz M.
The role of platelets for the pathophysiology of acute coronary syndromes.
Hamostaseologie.
2006;
26(2)
114-118
-
9
Ruggeri Z M.
New insights into the mechanisms of platelet adhesion and aggregation.
Semin Hematol.
1994;
31(11)
229-239
-
10
Jackson S P.
The growing complexity of platelet aggregation.
Blood.
2007;
109(12)
5087-5095
-
11
Nesbitt W S, Westein E, Tovar-Lopez F J et al..
A shear gradient-dependent platelet aggregation mechanism drives thrombus formation.
Nat Med.
2009;
15(6)
665-673
-
12
Heeschen C, Dimmeler S, Hamm C W et al..
Soluble CD40 ligand in acute coronary syndromes.
N Engl J Med.
2003;
348(12)
1104-1111
-
13
Ross R.
Atherosclerosis–an inflammatory disease.
N Engl J Med.
1999;
340
115-126
-
14
Hansson G K.
Inflammation, atherosclerosis, and coronary artery disease.
N Engl J Med.
2005;
352(2)
1685-1695
-
15
Massberg S, Brand K, Gruner S et al..
A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.
J Exp Med.
2002;
196(7)
887-896
-
16
Huo Y, Schober A, Forlow S B et al..
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
Nat Med.
2003;
9(1)
61-67
-
17
Gawaz M, Langer H, May A E.
Platelets in inflammation and atherogenesis.
J Clin Invest.
2005;
115(12)
3378-3384
-
18
Theilmeier G, Michiels C, Spaepen E et al..
Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia.
Blood.
2002;
99(12)
4486-4493
-
19
Jorgensen L.
The role of platelets in the initial stages of atherosclerosis.
J Thromb Haemost.
2006;
4(6)
1443-1449
-
20
Bombeli T, Schwartz B R, Harlan J M.
Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha.
J Exp Med.
1998;
187(3)
329-339
-
21
Gawaz M, Neumann F J, Ott I, Schiessler A, Schomig A.
Platelet function in acute myocardial infarction treated with direct angioplasty.
Circulation.
1996;
93(2)
229-237
-
22
Gawaz M, Neumann F J, Dickfeld T et al..
Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction.
Circulation.
1997;
96(6)
1809-1818
-
23
Gawaz M, Stellos K, Langer H F.
Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells.
J Thromb Haemost.
2008;
6(2)
235-242
-
24
Frenette P S, Denis C V, Weiss L et al..
P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo.
J Exp Med.
2000;
191(8)
1413-1422
-
25
Burger P C, Wagner D D.
Platelet P-selectin facilitates atherosclerotic lesion development.
Blood.
2003;
101(7)
2661-2666
-
26
Gawaz M P, Loftus J C, Bajt M L et al..
Ligand bridging mediates integrin alpha IIb beta 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions.
J Clin Invest.
1991;
88(4)
1128-1134
-
27
Massberg S, Enders G, Matos F C et al..
Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo.
Blood.
1999;
94(11)
3829-3838
-
28
Massberg S, Schurzinger K, Lorenz M et al..
Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb.
Circulation.
2005;
112(8)
1180-1188
-
29
Gawaz M, Brand K, Dickfeld T et al..
Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis.
Atherosclerosis.
2000;
148(1)
75-85
-
30
Celik S, Langer H, Stellos K et al..
Platelet-associated LIGHT (TNFSF14) mediates adhesion of platelets to human vascular endothelium.
Thromb Haemost.
2007;
98(4)
798-805
-
31
Langer H, May A E, Bultmann A, Gawaz M.
ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.
Thromb Haemost.
2005;
94(3)
555-561
-
32
Seizer P, Borst O, Langer H F et al..
EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction.
Thromb Haemost.
2009;
101(4)
682-686
-
33
von Hundelshausen P, Weber K S, Huo Y et al..
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.
Circulation.
2001;
103(13)
1772-1777
-
34
von Hundelshausen P, Weber C.
Platelets as immune cells: bridging inflammation and cardiovascular disease.
Circ Res.
2007;
100(1)
27-40
-
35
Langer H F, Gawaz M.
Platelet-vessel wall interactions in atherosclerotic disease.
Thromb Haemost.
2008;
99(3)
480-486
-
36
Blair P, Flaumenhaft R.
Platelet alpha-granules: basic biology and clinical correlates.
BloodRev.
2009;
23(4)
177-189
-
37
Schober A, Manka D, von Hundelshausen P et al..
Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury.
Circulation.
2002;
106(12)
1523-1529
-
38
Scheuerer B, Ernst M, Durrbaum-Landmann I et al..
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages.
Blood.
2000;
95(4)
1158-1166
-
39
Gawaz M, Neumann F J, Dickfeld T et al..
Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells.
Circulation.
1998;
98(12)
1164-1171
-
40
Elzey B D, Tian J, Jensen R J et al..
Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments.
Immunity.
2003;
19(1)
9-19
-
41
Boilard E, Nigrovic P A, Larabee K et al..
Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.
Science.
2010;
327(5965)
580-583
-
42
Gawaz M, Fateh-Moghadam S, Pilz G, Gurland H J, Werdan K.
Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure.
Eur J Clin Invest.
1995;
25(11)
843-851
-
43
Gawaz M, Reininger A, Neumann F J.
Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium.
Thromb Res.
1996;
83(5)
341-349
-
44
Wegmann F, Petri B, Khandoga A G et al..
ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability.
J Exp Med.
2006;
203(7)
1671-1677
-
45
Langer H F, Chavakis T.
Leukocyte-endothelial interactions in inflammation.
J Cell Mol Med.
2009;
13(7)
1211-1220
-
46
Simon D I, Chen Z, Xu H et al..
Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).
J Exp Med.
2000;
192(2)
193-204
-
47
Santoso S, Sachs U J, Kroll H et al..
The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1.
J Exp Med.
2002;
196(5)
679-691
-
48
Ehlers R, Ustinov V, Chen Z et al..
Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha.
J Exp Med.
2003;
198(7)
1077-1088
-
49
Weber C, Springer T A.
Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor.
J Clin Invest.
1997;
100(8)
2085-2093
-
50
Prokopi M, Pula G, Mayr U et al..
Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures.
Blood.
2009;
114(3)
723-732
-
51
Langer H F, Gawaz M.
Platelets in regenerative medicine.
Basic Res Cardiol.
2008;
103(4)
299-307
-
52
Langer H, May A E, Daub K et al..
Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro.
Circ Res.
2006;
98(2)
e2-e10
-
53
Massberg S, Konrad I, Schurzinger K et al..
Platelets secrete stromal cell-derived factor 1{alpha} and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo.
J Exp Med.
2006;
203(5)
1221-1233
-
54
Stellos K, Bigalke B, Langer H et al..
Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.
Eur Heart J.
2009;
30(5)
584-593
-
55
Stellos K, Langer H, Daub K et al..
Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells.
Circulation.
2008;
117(2)
206-215
-
56
Langer H F, Stellos K, Steingen C et al..
Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro.
J Mol Cell Cardiol.
2009;
47(2)
315-325
-
57
Stellos K, Langer H F, Gnerlich S et al..
Junctional adhesion molecule-A expressed on human CD34+ cells promotes adhesion on vascular wall and differentiation into endothelial progenitor cells.
Arterioscler Thromb Vasc Biol.
2010;
, In press
-
58
Abi-Younes S, Sauty A, Mach F et al..
The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques.
Circ Res.
2000;
86(2)
131-138
-
59
Stellos K, Langer H, Daub K et al..
Platelet-Derived Stromal Cell Derived Factor-1 Regulates Adhesion and Promotes Differentiation of Human CD34+ Cells to Endothelial Progenitor Cells.
Circulation.
2008;
117(2)
206-215
-
60
Jin D K, Shido K, Kopp H G et al..
Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.
Nat Med.
2006;
12(5)
557-567
-
61
Langer H F, May A E, Vestweber D et al..
Platelet-induced differentiation of endothelial progenitor cells.
Semin Thromb Hemost.
2007;
33(2)
136-143
-
62
Daub K, Langer H, Seizer P et al..
Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells.
FASEB J.
2006;
20(14)
2559-2561
-
63
Langer H F, von der Ruhr J, Daub K et al..
Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces re-endothelialization of vascular lesions.
J Mol Med.
2010;
, In press
-
64
Libby P, Theroux P.
Pathophysiology of coronary artery disease.
Circulation.
2005;
111(25)
3481-3488
-
65
Daub K, Lindemann S, Langer H et al..
The evil in atherosclerosis: adherent platelets induce foam cell formation.
Semin Thromb Hemost.
2007;
33(2)
173-178
-
66
De Meyer G R, De Cleen D M, Cooper S et al..
Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis.
Circ Res.
2002;
90(11)
1197-1204
-
67
Jans D M, Martinet W, Fillet M et al..
Effect of non-steroidal anti-inflammatory drugs on amyloid-beta formation and macrophage activation after platelet phagocytosis.
J Cardiovasc Pharmacol.
2004;
43(3)
462-470
-
68
Liu K, Victora G D, Schwickert T A et al..
In vivo analysis of dendritic cell development and homeostasis.
Science.
2009;
324(5925)
392-397
-
69
Yilmaz A, Weber J, Cicha I et al..
Decrease in circulating myeloid dendritic cell precursors in coronary artery disease.
J Am Coll Cardiol.
2006;
48(1)
70-80
-
70
Paulson K E, Zhu S N, Chen M et al..
Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.
Circ Res.
2010;
106(2)
383-390
-
71
Gautier E L, Huby T, Saint-Charles F et al..
Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis.
Circulation.
2009;
119(17)
2367-2375
-
72
Langer H F, Daub K, Braun G et al..
Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro.
Arterioscler Thromb Vasc Biol.
2007;
27(6)
1463-1470
-
73
Hilf N, Singh-Jasuja H, Schwarzmaier P et al..
Human platelets express heat shock protein receptors and regulate dendritic cell maturation.
Blood.
2002;
99(10)
3676-3682
-
74
Hamzeh-Cognasse H, Cognasse F, Palle S et al..
Direct contact of platelets and their released products exert different effects on human dendritic cell maturation.
BMC Immunol.
2008;
9
54
Harald LangerM.D.
Medizinische Klinik III, Eberhard-Karls-Universität Tübingen
Otfried-Müller-Str.10, D-72076 Tübingen, Germany
Email: harald.langer@med.uni-tuebingen.de